Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lera

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1997
Stereotypies in Wilson's diseaseA A Yorio, J C Mesri, M A Pagano, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1994
Motor response to apomorphine and levodopa in asymmetric Parkinson's diseaseM Rodriguez, G Lera, J Vaamonde, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 14, 2000
A combined pattern of movement disorders resulting from posterolateral thalamic lesions of a vascular nature: a syndrome with clinico-radiologic correlationG Lera, O Scipioni, S Garcia, et al.
Neurologia (Barcelona, Spain)|May 1, 1992
[Motor fluctuations in Parkinson disease: risk factors]F Grandas, M R Luquin, M Rodríguez, et al.
Clinical Neuropharmacology|February 1, 1992
Differences in the motor response to apomorphine between untreated and fluctuating patients with Parkinson's diseaseF Grandas, S T Gancher, M Rodriguez, et al.
Neurology|January 9, 2001
The evolution and origin of motor complications in Parkinson's diseaseJ A Obeso, M C Rodriguez-Oroz, P Chana, et al.
Neurology|July 1, 1992
Time interval between repeated injections conditions the duration of motor improvement to apomorphine in Parkinson's diseaseF Grandas, S Gancher, G Lera, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Neuroleptic malignant syndrome treated with subcutaneous lisuride infusionM E Rodriguez, M R Luquin, G Lera, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Overcoming pharmacokinetic problems in the treatment of Parkinson's diseaseJ A Obeso, J Vaamonde, F Grandas, et al.
Neurology|November 1, 1989
Motor complications associated with chronic levodopa therapy in Parkinson's diseaseJ A Obeso, F Grandas, J Vaamonde, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1997
Stereotypies in Wilson's diseaseA A Yorio, J C Mesri, M A Pagano, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1994
Motor response to apomorphine and levodopa in asymmetric Parkinson's diseaseM Rodriguez, G Lera, J Vaamonde, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 14, 2000
A combined pattern of movement disorders resulting from posterolateral thalamic lesions of a vascular nature: a syndrome with clinico-radiologic correlationG Lera, O Scipioni, S Garcia, et al.
Neurologia (Barcelona, Spain)|May 1, 1992
[Motor fluctuations in Parkinson disease: risk factors]F Grandas, M R Luquin, M Rodríguez, et al.
Clinical Neuropharmacology|February 1, 1992
Differences in the motor response to apomorphine between untreated and fluctuating patients with Parkinson's diseaseF Grandas, S T Gancher, M Rodriguez, et al.
Neurology|January 9, 2001
The evolution and origin of motor complications in Parkinson's diseaseJ A Obeso, M C Rodriguez-Oroz, P Chana, et al.
Neurology|July 1, 1992
Time interval between repeated injections conditions the duration of motor improvement to apomorphine in Parkinson's diseaseF Grandas, S Gancher, G Lera, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Neuroleptic malignant syndrome treated with subcutaneous lisuride infusionM E Rodriguez, M R Luquin, G Lera, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Overcoming pharmacokinetic problems in the treatment of Parkinson's diseaseJ A Obeso, J Vaamonde, F Grandas, et al.
Neurology|November 1, 1989
Motor complications associated with chronic levodopa therapy in Parkinson's diseaseJ A Obeso, F Grandas, J Vaamonde, et al.
Pageof 3